KYTX Overview
Upcoming Projects (KYTX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (KYTX)
-
A Third View: Delving into the phase 1/2 clinical trial data regarding Kyverna Therapeutics’ CAR-T therapeutic for autoimmune disease, KYV-101.
Ticker: KYTX
Executed On: Jul 26, 2024 at 10:00 AM EDT -
A Second View: Delving into the phase 1/2 clinical trial data regarding Kyverna Therapeutics’ CAR-T therapeutic for autoimmune disease, KYV-101.
Ticker: KYTX
Executed On: Jun 27, 2024 at 12:00 PM EDT -
Delving into the phase 1/2 clinical trial data regarding Kyverna Therapeutics’ CAR-T therapeutic for autoimmune disease, KYV-101.
Ticker: KYTX
Executed On: Jun 21, 2024 at 12:30 PM EDT -
A Third Look: Discussing the potential of CAR-T applications in immunology and autoimmune diseases.
Tickers: AZN, KYTX, CABA, NKTX, GRCL, Artiva Biotherapeutics
Executed On: May 30, 2024 at 04:30 PM EDT -
A Second Look: Discussing the potential of CAR-T applications in immunology and autoimmune diseases.
Tickers: AZN, KYTX, CABA, NKTX, GRCL, Artiva Biotherapeutics
Executed On: May 24, 2024 at 09:00 AM EDT -
Discussing the potential of CAR-T applications in immunology and autoimmune diseases.
Tickers: KYTX, CABA, NKTX, GRCL, AZN, Artiva Biotherapeutics
Executed On: May 23, 2024 at 11:00 AM EDT -
A Third Opinion: Discussing the treatment of generalized and refractory myasthenia gravis and the potential of anti-CD19 CAR T cells.
Ticker: KYTX
Executed On: Feb 15, 2024 at 01:30 PM EST -
A Second Opinion: Discussing the treatment of generalized and refractory myasthenia gravis and the potential of anti-CD19 CAR T cells.
Ticker: KYTX
Executed On: Feb 15, 2024 at 09:30 AM EST -
Discussing the treatment of generalized and refractory myasthenia gravis and the potential of anti-CD19 CAR T cells.
Ticker: KYTX
Executed On: Jan 30, 2024 at 02:30 PM EST
Upcoming & Overdue Catalysts (KYTX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (KYTX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
